Bitte warte einen Moment, wir laden die Tabellendaten
Novo Nordisk A/S-Community
About Novo Nordisk A/S
What is Novo Nordisk A/S?
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
The current price of Novo Nordisk A/S in the market is 35,33 €, with a 24-hour trading volume of 821,16M €. The asset's market cap is 156,72B €, after moving 6.88% in the last day.
Tokenized Novo Nordisk A/S is trading at 35,72 €, with a tokenized market cap of 2,92M € and a 24-hour trading volume of 707,77K €. The tokenized asset has moved 3.54% in the past 24 hours.